BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 32973794)

  • 1. To Remember or to Forget: The Role of Good and Bad Memories in Adoptive T Cell Therapy for Tumors.
    Mondino A; Manzo T
    Front Immunol; 2020; 11():1915. PubMed ID: 32973794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-resident memory-like T cells in tumor immunity: Clinical implications.
    Dhodapkar MV; Dhodapkar KM
    Semin Immunol; 2020 Jun; 49():101415. PubMed ID: 33011063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of memory T cell subsets for adoptive immunotherapy.
    Busch DH; Fräßle SP; Sommermeyer D; Buchholz VR; Riddell SR
    Semin Immunol; 2016 Feb; 28(1):28-34. PubMed ID: 26976826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-resident memory CD8
    Wang T; Shen Y; Luyten S; Yang Y; Jiang X
    Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
    Gao A; Liu X; Lin W; Wang J; Wang S; Si F; Huang L; Zhao Y; Sun Y; Peng G
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation and Regulation of T
    Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K
    Front Immunol; 2021; 12():669474. PubMed ID: 34012451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.
    Payne KK; Bear HD; Manjili MH
    Future Oncol; 2014 Aug; 10(10):1779-94. PubMed ID: 25303057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of endogenous T cells for adoptive transfer.
    Yee C
    Immunol Rev; 2014 Jan; 257(1):250-63. PubMed ID: 24329802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Tissue Resident Memory T Cells.
    Mami-Chouaib F; Tartour E
    Front Immunol; 2019; 10():1018. PubMed ID: 31191515
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.
    Tantalo DG; Oliver AJ; von Scheidt B; Harrison AJ; Mueller SN; Kershaw MH; Slaney CY
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34035114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer.
    Beumer-Chuwonpad A; Taggenbrock RLRE; Ngo TA; van Gisbergen KPJM
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles of adoptive T cell therapy in cancer.
    Met Ö; Jensen KM; Chamberlain CA; Donia M; Svane IM
    Semin Immunopathol; 2019 Jan; 41(1):49-58. PubMed ID: 30187086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive T cell therapy: points to consider.
    Yee C
    Curr Opin Immunol; 2018 Apr; 51():197-203. PubMed ID: 29730057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resident Memory-Like Tumor-Infiltrating Lymphocytes (TIL
    Smazynski J; Webb JR
    Front Immunol; 2018; 9():1741. PubMed ID: 30093907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer.
    Kumar A; Watkins R; Vilgelm AE
    Front Immunol; 2021; 12():690499. PubMed ID: 34140957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory CD8
    Han J; Khatwani N; Searles TG; Turk MJ; Angeles CV
    Semin Immunol; 2020 Jun; 49():101435. PubMed ID: 33272898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.